Ajay Kumar/LinkedIn
Mar 2, 2026, 16:09
Ajay Kumar: The Progression of HDFN – From Fetal Anemia to Kernicterus
Ajay Kumar, Senior Resident at Geetanjali Hospital, shared a post on LinkedIn:
“As a transfusion medicine specialist, I often emphasize the importance of early Antibody Screening in pregnancy.
Haemolytic Disease of the Fetus and Newborn (HDFN) is a preventable yet potentially life-threatening condition.
Timely antenatal antibody screening, appropriate monitoring, and interventions like intrauterine transfusion (IUT) or phototherapy can save lives and prevent permanent neurological damage.
Prevention and vigilance remain our strongest tools.”
Stay updated with Hemostasis Today.
-
Mar 2, 2026, 16:01Samwel Mikaye: Understanding Direct and Indirect Coombs Testing in Diagnosing Immune-Mediated Hemolysis
-
Mar 2, 2026, 15:58Danny Hsu: The Next Frontier in Anticoagulation Beyond DOACs
-
Mar 2, 2026, 15:56Khaled Musallam: UAE Approves Pyrukynd for Both Alpha and Beta Thalassemia
-
Mar 2, 2026, 15:42Abdulrahman Nasiri։ Decade of Evidence Supports ASCT2 in Relapsed Multiple Myeloma
-
Mar 2, 2026, 15:38Aharon Tsaturyan: Honored to Present the First Global Disease Registry Program from Armenia at Vickino Day
-
Mar 2, 2026, 15:27Advancing Education, Access, and Community Support During Bleeding Disorders Awareness Month – NBDF
-
Mar 2, 2026, 15:16Tina Liedtky: Thermo Fisher Scientific Launches New Test to Help Guide Tacrolimus Dosing
-
Mar 2, 2026, 15:08Joseph Italiano: Exploring the Intersection of Megakaryocyte Biology and Chronic Kidney Disease
-
Mar 2, 2026, 13:42Michael Makris: How Early Can Hemlibra Be Started?